These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 23202126)

  • 1. Dclk1 distinguishes between tumor and normal stem cells in the intestine.
    Nakanishi Y; Seno H; Fukuoka A; Ueo T; Yamaga Y; Maruno T; Nakanishi N; Kanda K; Komekado H; Kawada M; Isomura A; Kawada K; Sakai Y; Yanagita M; Kageyama R; Kawaguchi Y; Taketo MM; Yonehara S; Chiba T
    Nat Genet; 2013 Jan; 45(1):98-103. PubMed ID: 23202126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A tumor stem cell-specific marker identified by lineage tracing in the intestine].
    Seno H; Yamaga Y; Nakanishi Y; Chiba T
    Nihon Rinsho; 2015 May; 73(5):850-4. PubMed ID: 25985642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
    Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
    Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profile of Dclk1
    Yamaga Y; Fukuda A; Nakanishi Y; Goto N; Matsumoto Y; Yoshioka T; Maruno T; Chiba T; Seno H
    Dig Liver Dis; 2018 Dec; 50(12):1353-1361. PubMed ID: 30001952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.
    Chandrakesan P; Weygant N; May R; Qu D; Chinthalapally HR; Sureban SM; Ali N; Lightfoot SA; Umar S; Houchen CW
    Oncotarget; 2014 Oct; 5(19):9269-80. PubMed ID: 25211188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage tracing and targeting of IL17RB
    Goto N; Fukuda A; Yamaga Y; Yoshikawa T; Maruno T; Maekawa H; Inamoto S; Kawada K; Sakai Y; Miyoshi H; Taketo MM; Chiba T; Seno H
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12996-13005. PubMed ID: 31182574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.
    Vedeld HM; Skotheim RI; Lothe RA; Lind GE
    Epigenetics; 2014 Mar; 9(3):346-50. PubMed ID: 24384857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor-specific stem cell.
    Metcalfe C; de Sauvage FJ
    Nat Genet; 2013 Jan; 45(1):7-9. PubMed ID: 23268130
    [No Abstract]   [Full Text] [Related]  

  • 9. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
    Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma.
    Reineking W; Schauerte IE; Junginger J; Hewicker-Trautwein M
    Vet Pathol; 2022 May; 59(3):415-426. PubMed ID: 35220825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner.
    Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z
    Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-195 regulates Tuft cell function in the intestinal epithelium by altering translation of DCLK1.
    Kwon MS; Chung HK; Xiao L; Yu TX; Wang SR; Piao JJ; Rao JN; Gorospe M; Wang JY
    Am J Physiol Cell Physiol; 2021 Jun; 320(6):C1042-C1054. PubMed ID: 33788631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lived intestinal tuft cells serve as colon cancer-initiating cells.
    Westphalen CB; Asfaha S; Hayakawa Y; Takemoto Y; Lukin DJ; Nuber AH; Brandtner A; Setlik W; Remotti H; Muley A; Chen X; May R; Houchen CW; Fox JG; Gershon MD; Quante M; Wang TC
    J Clin Invest; 2014 Mar; 124(3):1283-95. PubMed ID: 24487592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.
    Ikezono Y; Koga H; Akiba J; Abe M; Yoshida T; Wada F; Nakamura T; Iwamoto H; Masuda A; Sakaue T; Yano H; Tsuruta O; Torimura T
    Mol Cancer Res; 2017 Jun; 15(6):744-752. PubMed ID: 28179411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brg1 is required to maintain colorectal cancer stem cells.
    Yoshikawa T; Fukuda A; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Kawada K; Takaishi S; Seno H
    J Pathol; 2021 Nov; 255(3):257-269. PubMed ID: 34415580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
    Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
    Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.
    Ladang A; Rapino F; Heukamp LC; Tharun L; Shostak K; Hermand D; Delaunay S; Klevernic I; Jiang Z; Jacques N; Jamart D; Migeot V; Florin A; Göktuna S; Malgrange B; Sansom OJ; Nguyen L; Büttner R; Close P; Chariot A
    J Exp Med; 2015 Nov; 212(12):2057-75. PubMed ID: 26527802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.